S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
(Ad)
The audience GASPED when he revealed how you could collect 100% on your savings every year... for life.

NYSE:PEN - Penumbra Stock Price, Forecast & News

$160.36
-0.07 (-0.04 %)
(As of 01/20/2020 04:00 PM ET)
Today's Range
$159.63
Now: $160.36
$162.01
50-Day Range
$156.35
MA: $162.05
$174.46
52-Week Range
$122.40
Now: $160.36
$185.70
Volume198,591 shs
Average Volume271,852 shs
Market Capitalization$5.60 billion
P/E Ratio127.27
Dividend YieldN/A
Beta0.73
Penumbra, Inc designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone510-748-3200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$444.94 million
Cash Flow$0.71 per share
Book Value$12.24 per share

Profitability

Net Income$6.60 million

Miscellaneous

Employees2,200
Market Cap$5.60 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive PEN News and Ratings via Email

Sign-up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Penumbra (NYSE:PEN) Frequently Asked Questions

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra Inc (NYSE:PEN) announced its earnings results on Thursday, November, 7th. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.18 by $0.07. The business had revenue of $139.50 million for the quarter, compared to the consensus estimate of $133.98 million. Penumbra had a return on equity of 7.23% and a net margin of 8.69%. The company's revenue was up 24.8% on a year-over-year basis. During the same period last year, the business posted $0.17 EPS. View Penumbra's Earnings History.

When is Penumbra's next earnings date?

Penumbra is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Penumbra.

What price target have analysts set for PEN?

7 brokerages have issued 1-year price objectives for Penumbra's shares. Their forecasts range from $180.00 to $200.00. On average, they anticipate Penumbra's stock price to reach $191.40 in the next twelve months. This suggests a possible upside of 19.4% from the stock's current price. View Analyst Price Targets for Penumbra.

What is the consensus analysts' recommendation for Penumbra?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Penumbra.

Has Penumbra been receiving favorable news coverage?

Media coverage about PEN stock has trended extremely negative this week, according to InfoTrie. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Penumbra earned a coverage optimism score of -5.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Penumbra.

Who are some of Penumbra's key competitors?

What other stocks do shareholders of Penumbra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include Netflix (NFLX), NVIDIA (NVDA), Alibaba Group (BABA), Splunk (SPLK), Intuitive Surgical (ISRG), salesforce.com (CRM), Paypal (PYPL), AbbVie (ABBV), Twilio (TWLO) and Adobe (ADBE).

Who are Penumbra's key executives?

Penumbra's management team includes the folowing people:
  • Mr. Adam Elsesser, Co Founder, Chairman, CEO & Pres (Age 57)
  • Dr. Arani Bose, Co-Founder, Chief Innovator and Director (Age 57)
  • Mr. Sridhar N. Kosaraju, CFO and Head of Strategy (Age 41)
  • Ms. Lynn Rothman, Chief Bus. Officer and Exec. VP (Age 58)
  • Mr. Daniel Donen Davis, Chief Commercial Officer (Age 41)

Who are Penumbra's major shareholders?

Penumbra's stock is owned by many different of institutional and retail investors. Top institutional investors include Louisiana State Employees Retirement System (0.02%), State of Alaska Department of Revenue (0.02%), Alpine Global Management LLC (0.01%), Sciencast Management LP (0.01%) and Advisors Capital Management LLC (0.00%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Coyne David, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Institutional Ownership Trends for Penumbra.

Which major investors are selling Penumbra stock?

PEN stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Penumbra company stock in the last year include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, Harpreet Grewal, James Robert Pray, Lynn Rothman, Sridhar Kosaraju and Thomas Wilder. View Insider Buying and Selling for Penumbra.

Which major investors are buying Penumbra stock?

PEN stock was purchased by a variety of institutional investors in the last quarter, including Alpine Global Management LLC, Sciencast Management LP, Advisors Capital Management LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Penumbra.

How do I buy shares of Penumbra?

Shares of PEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Penumbra's stock price today?

One share of PEN stock can currently be purchased for approximately $160.36.

How big of a company is Penumbra?

Penumbra has a market capitalization of $5.60 billion and generates $444.94 million in revenue each year. The company earns $6.60 million in net income (profit) each year or $0.51 on an earnings per share basis. Penumbra employs 2,200 workers across the globe.View Additional Information About Penumbra.

What is Penumbra's official website?

The official website for Penumbra is http://www.penumbrainc.com/.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The company can be reached via phone at 510-748-3200 or via email at [email protected]


MarketBeat Community Rating for Penumbra (NYSE PEN)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  603 (Vote Outperform)
Underperform Votes:  210 (Vote Underperform)
Total Votes:  813
MarketBeat's community ratings are surveys of what our community members think about Penumbra and other stocks. Vote "Outperform" if you believe PEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: Trading Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel